Faculty of Medicine Ain Shams University
Cairo, Egypt
NCT Number: NCT07156968
This study aims to compare effect of adding fentanyl or dexmetomidine on duration of motor and sensory block after spinal anesthesia with prilocaine during day case perianal surgery and whether it impact time to discharge home.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Cairo, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A peripheral intravenous (IV) catheter will be inserted, and a 7 mL kg-1 crystalloid infusion will be initiated. The patients will be premedicated with 0.03 mg kg-1 midazolam IV. Heart rate and peripheral oxygen saturation (SpO2) will be monitored continuously; systolic, diastolic, and mean arterial pressure (MAP) will be measured noninvasively at 5 min intervals during the procedure and at 15 min intervals during the post anesthesia care unit (PACU) stay. The baseline values will be recorded. Nasal oxygen 2 L min-1 will be administered during the whole procedure
Other names: prilocaine-fentanyl, prilocaine-dexametomidine
Time frame: at 1 min intervals until the maximum block will be achieved and at 15 min intervals thereafter until the block resolved to S3 dermatome.
The sensory block will be measured at the midclavicular line with a pinprick test (via a 22 gauge hypodermic needle)
Time frame: Home discharge will be assessed as the time from the end of surgery until the patients reach a post-anesthesia discharge score
(modified Alderts score) ≥9, able to void spontaneously and the sensory block resolves to the S3 dermatome.
Time frame: within 6 hours after surgery
The postoperative urinary retention (POUR) will be evaluated at hourly intervals in the PACU and ward; ultrasonic bladder scanning will be used for this purpose. If the bladder volume exceeds 500 mL and the patient has not voided spontaneously, urinary catheterization will be introduced.
Ain Shams University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06333145
Effect of Drug
Wuhan, Hubei, China
View Trial DetailsNCT07166640
Effect of Drug
Kocaeli, Izmit, Turkey (Türkiye)
View Trial DetailsNCT07162805
Effect of Drug
Kocaeli, Izmit, Turkey (Türkiye)
View Trial DetailsNCT06114641
Effect of Drug, Safety Issues
Yogyakarta, D.I.Yogyakarta, Indonesia
View Trial Details